Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Pitta, Denise da R ^a   Sarian, Luis O ^a   Barreta, Amilcar ^a   Campos, Elisabete A ^a   Andrade, Liliana Lucci de Angelo ^a   Fachini, Ana Maria D ^a   Campbell, Leonardo M ^a   Derchain, Sophie ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

CA125; HE4; Ovarian tumors; Prediction of malignancy; ROMA; Specific symptoms

Indexed keywords

CA 125 ANTIGEN; HUMAN EPIDIDYMIS PROTEIN 4;

ABDOMINAL MASS; ADNEXA DISEASE; ALGORITHM; ARTICLE; BACKACHE; BRAZIL; BRAZILIAN; CA 125 ANTIGEN BLOOD LEVEL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EATING; ETHNIC GROUP; FEMALE; GYNECOLOGIC SURGERY; HEALTH CARE UTILIZATION; HOSPITAL SERVICE; HUMAN; HUMAN EPIDIDYMIS PROTEIN 4 BLOOD LEVEL; LEG SWELLING; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; OVARY CANCER; OVARY TUMOR; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK OF OVARIAN MALIGNANCY ALGORITHM; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYMPTOM INDEX;

ADULT; AGED; ALGORITHMS; BRAZIL; CA-125 ANTIGEN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARY; PREOPERATIVE PERIOD; PROGNOSIS; PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84884192357     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-423     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. Epub 2011 Feb 4. Erratum in: CA Cancer J Clin 2011, 61(2):134, 10.3322/caac.20107, 21296855.
2. INCA- Instituto Nacional de Câncer Estimativa 2012, http://www.inca.gov.br/estimativa/2012/ [Accessed 10 October 2011]; http://www.inca.gov.br/estimativa/2012/, INCA- Instituto Nacional de Câncer.
3. Vernooij F, Heintz AP, Coebergh JW, Massuger LF, Witteveen PO, van der Graaf Y. Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 2009, 112(3):455-461. 10.1016/j.ygyno.2008.11.011, 19136148.
4. Geomini P, Kruitwagen R, Bremer GL, Cnossen J, Mol BW. The accuracy of risk scores in predicting ovarian malignancy: a systematic review. Obstet Gynecol 2009, 113(2 Pt 1):384-394.
5. Kaijser J, Bourne T, Valentin L, Sayasneh A, Van-Holsbeke C, Vergote I, Testa AC, Franchi D, Van-Calster B, Timmerman D. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Ultrasound Obstet Gynecol 2013, 41(1):9-20. 10.1002/uog.12323, 23065859.
6. Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van-Holsbeke C, Paladini D, Van-Calster B, Vergote I, Van-Huffel S, Valentin L. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol 2008, 31:681-690. 10.1002/uog.5365, 18504770.
7. Hartman CA, Juliato CR, Sarian LO, Toledo MC, Jales RM, Morais SS, Pitta DR, Marussi EF, Derchain S. Ultrasound criteria and CA-125 as predictive variables of ovarian cancer in women with adnexal tumors. Ultrasound Obstet Gynecol 2012, 40(3):360-366. 10.1002/uog.11201, 22648861.
8. Vine MF, Calingaert B, Berchuck A, Schildkraut JM. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol 2003, 90(1):75-82. 10.1016/S0090-8258(03)00175-6, 12821345.
9. Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007, 109:221-227. 10.1002/cncr.22371, 17154394.
10. Bankhead CR, Kehoe ST, Austoker J. Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG 2005, 112(7):857-865. 10.1111/j.1471-0528.2005.00572.x, 15957984.
11. Goff BA. Symptoms associated with ovarian cancer. Clin Obstet Gynecol 2012, 55(1):36-42. 10.1097/GRF.0b013e3182480523, 22343227.
12. Van-Calster B, Timmerman D, Bourne T, Testa AC, Van-Holsbeke C, Domali E, Jurkovic D, Neven P, Van-Huffel S, Valentin L. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst 2007, 99(22):1706-1714. 10.1093/jnci/djm199, 18000221.
13. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Dresher CW, Paley P, Urban N. Combining a symptoms index with CA125 to improve detection of ovarian cancer. Cancer 2008, 113:484-489. 10.1002/cncr.23577, 2734274, 18615684.
14. Li F, Tie R, Chang K, Wang F, Deng S, Lu W, Yu L, Chen M. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis. BMC Cancer 2012, 12(1):258. 10.1186/1471-2407-12-258, 3443004, 22712526.
15. Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ, Kurman RJ, Bast RC, Skates SJ. Comparison of a novel multiple marker assay vs the risk of malignancy index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010, 203(3):228. e1-6, 3594101, 20471625.
16. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban N. Use of a symptom index, CA125 and HE4 to predict ovarian cancer. Gynecol Oncol 2010, 116(3):378-391. 10.1016/j.ygyno.2009.10.087, 2822097, 19945742.
17. Tavassoli FA, Deville P. Pathology and genetics of tumors of the breast and female genital organs. WHO Classification of tumors 2003, Lyon: IARC Press.
18. Development Core Team R. R: A language and environment for statistical computing 2011, Vienna, Austria: R Foundation for Statistical Computing, 3-900051-07-0, URL http://www.R-project.org/.
19. Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S. Symptoms of ovarian cancer. Obstet Gynecol 2001, 98:212-217. 10.1016/S0029-7844(01)01457-0, 11506835.
20. Bankhead CR, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, Mant D, Kehoe ST, Austoker J. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG 2008, 115(8):1008-1014. 10.1111/j.1471-0528.2008.01772.x, 2607526, 18651882.
21. Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963, 58:236-244.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
23. Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis. Cancer 2000, 89(10):2068-2075. 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z, 11066047.
24. Hippisley-Cox J, Coupland C. Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2013, 63(606):11-21.
25. Van-Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F, Timmerman D, De-Moor B, Vergote I. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm. Br J Cancer 2011, 5:863-870.
26. Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS. Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst 2010, 102:222-229. 10.1093/jnci/djp500, 2826180, 20110551.
27. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004, 291(22):2705-2712. 10.1001/jama.291.22.2705, 15187051.
28. Kurman RJ, Shih IM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011, 42(7):918-931. 10.1016/j.humpath.2011.03.003, 3148026, 21683865.
29. Brown PO, Palmer C. The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med 2009, 6(7):e1000114. 10.1371/journal.pmed.1000114, 2711307, 19636370.
30. Gilbert L, Basso O, Sampalis J, Karp I, Martins C, Feng J, Piedimonte S, Quintal L, Ramanakumar AV, Takefman J, Grigorie MS, Artho G, Krishnamurthy S. DOvEStudy Group Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project. Lancet Oncol 2012, 13(3):285-291. 10.1016/S1470-2045(11)70333-3, 22257524, DOvEStudy Group.
31. Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, Setälä M, Härkki P, Jalkanen J, Fraser J, Mäkinen J, Auranen A, Poutanen M, Perheentupa A. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 2009, 100:1-5. 10.1038/sj.bjc.6604767, 2634670, 19002176.
32. Chapron C, Santulli P, De-Ziegler D, Noel JC, Anaf V, Streuli I, Foulot H, Souza C, Borghese B. Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis. Hum Reprod 2012, 27:702-711. 10.1093/humrep/der462, 22252082.